Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs

Eur Respir J. 2021 Jan 14;57(1):2000751. doi: 10.1183/13993003.00751-2020. Print 2021 Jan.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dendritic Cells*
  • Forkhead Transcription Factors
  • Humans
  • Omalizumab*
  • T-Lymphocytes, Regulatory

Substances

  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Omalizumab